Hepatitis Monthly

Published by: Kowsar

Distribution of HCV Genotypes and RNA Viral Load Along with Hemato-Biochemical Analysis of HCV Patients in Rahim Yar Khan, Okara and Toba Tek Singh Districts of Punjab, Pakistan

Suliman Qadir Afridi 1 , Nasar Khan 2 , Muhammad Akmal 2 , Sardar Ali 2 , Attaullah S. 2 , Sulaiman Bahadar 2 , Abdul Aziz 2 , Nasir Ali 3 , 4 , 7 , Firasat Hussain 5 , Furqan Awan 6 and Muhammad Muddassir Ali 7 , *
Authors Information
1 Department of Microbiology , University of veterinary and animal sciences, Lahore, 54000, Pakistan
2 Department of Microbiology, Kohat University of Science and Technology, Kohat 26000, Pakistan
3 Departamento de Engenharia de Bioprocessos e Biotecnologia, Universidade Federal do Paraná (UFPR), Curitiba, Parana, Brazil
4 Instituto de Biologia Molecular do Paraná (IBMP), FIOCRUZ, Curitiba, Parana, Brazil
5 Yunnan Institute of Microbiology, school of life sciences, Yunnan university, kuming, China
6 Department of Epidemiology and Public Health, University of veterinary and animal sciences, Lahore, 54000, Pakistan
7 Institute of Biochemistry and Biotechnology, University of veterinary and animal sciences, Lahore, 54000, Pakistan
Article information
  • Hepatitis Monthly: July 2017, 17 (7); e58442
  • Published Online: July 24, 2017
  • Article Type: Research Article
  • Received: October 14, 2014
  • Revised: January 7, 2015
  • Accepted: June 21, 2017
  • DOI: 10.5812/hepatmon.58442

To Cite: Afridi S Q, Khan N, Akmal M, Ali S, S. A, et al. Distribution of HCV Genotypes and RNA Viral Load Along with Hemato-Biochemical Analysis of HCV Patients in Rahim Yar Khan, Okara and Toba Tek Singh Districts of Punjab, Pakistan, Hepat Mon. 2017 ;17(7):e58442. doi: 10.5812/hepatmon.58442.

Copyright: Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005; 42(4): 962-73[DOI][PubMed]
  • 2. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791): 571-83[DOI][PubMed]
  • 3. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995; 15(1): 41-63[DOI][PubMed]
  • 4. Simmonds P. Variability of hepatitis C virus. Hepatology. 1995; 21(2): 570-83[PubMed]
  • 5. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992; 16(2): 293-9[PubMed]
  • 6. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology. 1995; 22(4 Pt 1): 1050-6[PubMed]
  • 7. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 2008; 8: 69[DOI][PubMed]
  • 8. Ali A, Nisar M, Ahmad H, Saif N, Idrees M, Bajwa MA. Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan. Virol J. 2011; 8: 466[DOI][PubMed]
  • 9. Afridi SQ, Ali MM, Awan F, Zahid MN, Afridi IQ, Afridi SQ, et al. Molecular epidemiology and viral load of HCV in different regions of Punjab, Pakistan. Virol J. 2014; 11: 24[DOI][PubMed]
  • 10. Afridi SQ, Zahid MN, Shabbir MZ, Hussain Z, Mukhtar N, Tipu MY, et al. Prevalence of HCV genotypes in district Mardan. Virol J. 2013; 10: 90[DOI][PubMed]
  • 11. Attaullah S, Khan S, Ali I. Hepatitis C virus genotypes in Pakistan: a systemic review. Virol J. 2011; 8: 433[DOI][PubMed]
  • 12. Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. 2008; 41(1): 4-8[PubMed]
  • 13. Elasifer HA, Agnnyia YM, Al-Alagi BA, Daw MA. Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients. Virol J. 2010; 7: 317[DOI][PubMed]
  • 14. Ahmad W, Ijaz B, Javed FT, Jahan S, Shahid I, Khan FM, et al. HCV genotype distribution and possible transmission risks in Lahore, Pakistan. World J Gastroenterol. 2010; 16(34): 4321-8[PubMed]
  • 15. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology. 2003; 37(4): 802-9[DOI][PubMed]
  • 16. Ahmad W, Ijaz B, Javed FT, Kausar H, Sarwar MT, Gull S, et al. HCV genotype-specific correlation with serum markers: higher predictability for genotype 4a. Virol J. 2011; 8: 293[DOI][PubMed]
  • 17. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011; 31 Suppl 2: 61-80[DOI][PubMed]
  • 18. Butt S, Idrees M, Shahid M, Amin I, Younas S, Afzal S, et al. Change in hepatitis C virus clades: a cross-sectional study of chronic HCV patients in Pakistan from 2000-2010. Eur J Clin Microbiol Infect Dis. 2011; 30(5): 669-72[DOI][PubMed]
  • 19. Dalgard O, Bjoro K, Hellum KB, Myrvang B, Ritland S, Skaug K, et al. Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study. Hepatology. 2004; 40(6): 1260-5[DOI][PubMed]
  • 20. von Wagner M, Huber M, Berg T, Hinrichsen H, Rasenack J, Heintges T, et al. Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology. 2005; 129(2): 522-7[DOI][PubMed]
  • 21. Jimenez-Mendez R, Uribe-Salas F, Lopez-Guillen P, Cisneros-Garza L, Castaneda-Hernandez G. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico. Ann Hepatol. 2010; 9(1): 33-9[PubMed]
  • 22. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000; 342(17): 1266-71[DOI][PubMed]
  • 23. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol. 1992; 66(3): 1476-83[PubMed]
  • 24. Romeo R, Colombo M, Rumi M, Soffredini R, Del Ninno E, Donato MF, et al. Lack of association between type of hepatitis C virus, serum load and severity of liver disease. J Viral Hepat. 1996; 3(4): 183-90[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader